Post-market Surveillance of AI medical devices. With Dr Dan Mullarkey- Medical Director at Skin Analytics
Digital Health Section Podcast- Royal Society of Medicine
00:00
Challenges in Post-Market Surveillance of AI Medical Devices
The chapter focuses on the difficulties encountered in tracking and monitoring patients in dermatology pathways, stressing the importance of digitization for streamlined patient follow-ups. It discusses the significance of real-world evidence, collaboration with dermatologists and AI experts, and setting a sensitivity benchmark of 95% for AI performance. Furthermore, it explores the complexities of data sharing between NHS organizations and the speaker's organization for post-market clinical follow-up of AI medical devices, emphasizing joint data control and transparency.
Transcript
Play full episode
